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Study Strengths: 1. This was a well-crafted manuscript and of adequate length. 2. Research Question Novelty: This is an important initiative that seeks to address a pressing issue in delirium research, the standardization of reporting outcomes. 3. The appropriate registration with COMET and PROSPERO has been undertaken. Comments/Concerns: The following few comments/questions are seeking clarification on a few issues (separated by section) to further strengthen the manuscript. METHODS: Will the use of conference proceeding or "grey" literature be used as part of the search strategy for the SR? METHODS: Are the Author planning for any internal audit or testing phase for the title and abstract phase and/or full-text screen to ensure adequate observed agreement and kappa of the screens? Minor Concerns: 1. It would be helpful for the Authors to include a completed SPIRIT checklist with their submission.
REVIEWER
James L. Rudolph Brown University, Providence RI, USA I am an unpaid board member of the American Delirium Society which is being used as a recruitment site for this study. I have no other interests REVIEW RETURNED 17-Mar-2017
GENERAL COMMENTS
This is an exciting study and thank you for the broad international effort to pull this together. There are a couple concerns that relate to sampling bias from the experts. 1) Combining pediatric and adults into the same group will be challenging because the literature on pediatrics is just beginning to expand. As a result, there are few pediatric experts and their voice in the Delphi may be limited by a larger number of adult experts. Please consider modifying the Delphi to insure that pediatrics gets its time.
2) Recruiting from the three societies will bring you a cohort of delirium experts. The challenge will be relating this back to actual clinical practice, because the experts who attend these meetings tend to have a strong bias toward delirium. Please consider the representation on the panels has adequate clinical experience to make this a valuable clinical method 3) Thank you for including the qualitative interviews, they are an important piece of delirium. Please consider having representation from all groups (although palliative, dementia, and peds will be difficult) This study protocol clearly outlines a number of studies planned to be undertaken to arrive at a set of core outcomes for future delirium trials.
REVIEWER
It"s well written, and clearly written by the right people. The topic is extremely important. Currently interventions to treat or prevent delirium are. A main limitation of these studies has been the wide difference in outcomes used. It may well be that "traditional" outcomes such as mortality may not be as important as the relieving of distress, shortening of duration of delirium, or amelioration of longer term cognitive decline.
I have a few comments to make.
The authors have selected four groups of people at risk of delirium. I do wonder if a fifth could be considered, that of older people undertaking elective surgery, especially cardiac surgery or joint arthroplasty. Delirium rates post cardiac surgery are high (approx. 50%) and I appreciate a number of these may be covered by the group on ITU, however elective joint arthroplasty (rates 10-15%) would be missed by this.
I would add to the limitations the possibility that important outcomes identified may not be easy to ascertain in trials. It is possible that duration of delirium, or limitation of distress is important. Rigorous ascertainment of these would be difficult at present, and it may be that this would lead to work deriving methods to do this.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 1. Will the use of conference proceeding or "grey" literature be used as part of the search strategy for the SR? Response: We do not intend to search conference proceedings or grey literature beyond Prospero and the Joanna Briggs library as we feel a comprehensive database search will provide sufficient breadth of scope in terms of study outcomes and measures.
2. Are the Author planning for any internal audit or testing phase for the title and abstract phase and/or full-text screen to ensure adequate observed agreement and kappa of the screens? Response: We do not intend to assess agreement as the objective according to Cochrane guidelines is to resolve any disagreement through discussion between the two screeners and to defer to a third if required.
3. It would be helpful for the Authors to include a completed SPIRIT checklist with their submission. Response: We are not sure why this reviewer has requested a SPIRIT checklist. We are not conducting a clinical trial and there are no interventions associated with the study. Therefore we have not completed as most elements are not applicable but are happy to be advised by the editor regarding this.
Reviewer: 2 1. Combining pediatric and adults into the same group will be challenging because the literature on pediatrics is just beginning to expand. As a result, there are few pediatric experts and their voice in the Delphi may be limited by a larger number of adult experts. Please consider modifying the Delphi to insure that pediatrics gets its time.
We agree with the reviewer that it will be important to ensure paediatric representation. We have included the following with respect to our interview stage….. "For the patient groups representing high acuity settings, acute care settings, and palliative care, we will also target parents and where possible children that have experienced delirium".
Once we have completed the systematic review work we will have a clearer idea as to whether we need to separate paediatrics completely for the Delphi and nominal group technique process. Therefore we have added the following in the Delphi section: "For the patient groups representing high acuity settings, acute care settings, and palliative care, we will also aim to have a minimum of 5 participants representing paediatrics in each group if deemed appropriate to combine in the same COS development process following our systematic review work".
2. Recruiting from the three societies will bring you a cohort of delirium experts. The challenge will be relating this back to actual clinical practice, because the experts who attend these meetings tend to have a strong bias toward delirium. Please consider the representation on the panels has adequate clinical experience to make this a valuable clinical method. Response: We believe that having a distinct cohort of clinicians that do not meet the criteria of trailist/researcher i.e. are not authors of published (over last 10 years) or ongoing clinical trials evaluating interventions aimed at preventing or treating delirium as we have outlined in our sampling strategy should address this concern.
3. Thank you for including the qualitative interviews, they are an important piece of delirium. Please consider having representation from all groups (although palliative, dementia, and peds will be difficult) Response: again this is our intention, we will be seeking family and previous patients if practicable representative of each of our 4 patient groups and as above have clarified that we will be seeking input from parents and children.
Reviewer: 3 1. The authors have selected four groups of people at risk of delirium. I do wonder if a fifth could be considered, that of older people undertaking elective surgery, especially cardiac surgery or joint arthroplasty. Delirium rates post cardiac surgery are high (approx. 50%) and I appreciate a number of these may be covered by the group on ITU, however elective joint arthroplasty (rates 10-15%) would be missed by this. Response: We debated out groups over many months. Older people receiving elective surgery will be included either in the patient groups representing high acuity settings or acute care settings and therefore we do not feel warrants a separate group.
2. I would add to the limitations the possibility that important outcomes identified may not be easy to ascertain in trials. It is possible that duration of delirium, or limitation of distress is important. Rigorous ascertainment of these would be difficult at present, and it may be that this would lead to work deriving methods to do this. Response: We agree that there is the potential that patient/family interviews as well as additional outcomes suggested by Delphi participants may introduce outcomes that currently don"t have measures. We have added the following: Important outcomes are identified that are difficult to measure due to the absence of valid and reliable measures. 
GENERAL COMMENTS
This is an important international collaboration describing a protocol for the development of a core outcomes dataset for research purposes. The process described, once completed, will have significant impact in delirium research and ultimately delirium clinical management. This is a well-written and comprehensive protocol manuscript
